Evidence map›Paper›PMID 35859209›Full record

ArticlePediatrics2022

Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.

Glynnis A McDonnell, Beth N Peshkin, Tiffani A DeMarco, Susan K Peterson, Banu K Arun, Susan Miesfeldt, Suzanne C O'Neill, Katherine Schneider, Judy Garber, Claudine Isaacs and 2 more

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Glynnis A McDonnellLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Beth N PeshkinLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Tiffani A DeMarcoInova Schar Cancer Institute, Inova Health System, Fairfax, Virginia.
Susan K PetersonMD Anderson Cancer Center, Houston, Texas.
Banu K ArunMD Anderson Cancer Center, Houston, Texas.
Susan MiesfeldtMaine Medical Center Cancer Institute, Scarborough, Maine.
Suzanne C O'NeillLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Katherine SchneiderDana-Farber Cancer Institute, Boston, Massachusetts.
Judy GarberDana-Farber Cancer Institute, Boston, Massachusetts.
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
George LutaLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Kenneth P TercyakLombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Georgetown University · USDana-Farber Cancer Institute · USThe University of Texas MD Anderson Cancer Center · USInova Health System · USMaine Medical Center Research Institute · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Adolescents' Long-Term Adaptation to Familial Cancer RisksR01CA137625 · NCI · GEORGETOWN UNIVERSITY · PI TERCYAK, KENNETH · 2010 to 2014
$2.9M
Improving Genetic Counseling for BRCA+ MothersR01CA246589 · NCI · GEORGETOWN UNIVERSITY · PI PESHKIN, BETH N, TERCYAK, KENNETH · 2020 to 2024
$2.0M
Peer Support for Young Adult Women with High Breast Cancer RiskR01CA242750 · NCI · GEORGETOWN UNIVERSITY · PI O'NEILL, SUZANNE C., TERCYAK, KENNETH · 2020 to 2024
$1.8M
Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and ApplicationR01CA225646 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, LIANG, SHIH, YA-CHEN TINA · 2018 to 2022
$1.8M
Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and CostsR01CA207216 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHIH, YA-CHEN TINA · 2016 to 2020
$1.6M
BIOBEHAVIORAL RESEARCH IN PUBLIC HEALTH GENETICSK18HG006754 · NHGRI · GEORGETOWN UNIVERSITY · PI TERCYAK, KENNETH · 2011 to 2011
$89k
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA137625NCI NIH HHS R01 CA225646NCI NIH HHS R01 CA242750NCI NIH HHS R01 CA246589NHGRI NIH HHS K18 HG006754
6 · The paper itself

Abstract

backgroundIt is important to examine adolescent and young adult (AYA) children's long-term psychosocial and behavioral adaptation to disclosure of maternal BRCA-positive carrier status (BRCA+) to inform approaches for familial cancer risk communication, education, and counseling.

methodsMothers underwent BRCA genetic testing 1 to 5 years earlier. Group differences in AYAs' self-reported outcomes were analyzed by maternal health and carrier status, and child age and sex.

resultsA total of N = 272 AYAs were enrolled: 76.1% of their mothers were breast or ovarian cancer survivors and 17.3% were BRCA+. AYAs' cancer risk behavior (tobacco and alcohol use, physical activity) and psychologic distress levels did not vary by maternal status. In bivariate analyses, AYAs of cancer-surviving mothers believed themselves to be at greater risk for, and were more knowledgeable about, cancer than AYAs of mothers without cancer. AYAs of BRCA+ mothers were more concerned about cancer, held stronger beliefs about genetic risk, and placed a higher value on learning about genetics. In adjusted models, maternal cancer history (not BRCA+) remained associated with AYAs' greater perceptions of cancer risk (P = .002), and knowledge about cancer (P = .03) and its causes (P = .002).

conclusionsDisclosing maternal BRCA+ status did not influence children's lifestyle behavior or adversely affect quality of life long term. AYAs of BRCA+ mothers were more aware of and interested in genetic risk information. Such families may benefit from support to promote open communication about genetic testing choices.

Indexed as

Cancer SurvivorsNeoplasmsOvarian NeoplasmsAdolescentAdult ChildrenFemaleGenetic TestingHumansQuality of LifeYoung Adult

Identifiers

PMID35859209
PMCPMC10646493
OpenAlexW4286001059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.